mRNA Cancer Therapeutics Patent Landscape Report and Forecast 2024-2032
patents include unique methods for identifying and characterising CTCs without the need for enrichment, enhancing real-time cancer monitoring. Epic Sciences’ contributions to the patent landscape reflect their innovative approach to non-invasive cancer diagnostics and personalised treatment strategies.
- Ventana Medical Systems Inc. (Roche Group)
- Curis Inc.
Key Questions Answered in the Circulating Tumor Cells Patent Landscape Report
- Which companies are the main players in the circulating tumor cells patent landscape?
- How are patents for circulating tumor cells distributed across different regions?
- What are the new and emerging trends in circulating tumor cell patents?
- How has the patent landscape for circulating tumor cells changed over time?
- What strategic insights are crucial for industry players and investors in the CTC field?
- What technologies are most commonly patented in the circulating tumor cells industry?
- How do different patent strategies affect competitive advantage in the CTC industry?
- What are the broader implications of patent filings in the circulating tumor cells sector?
- What are the main challenges and opportunities in the CTC patent landscape?
- What regulatory and legal factors must be considered in the CTC patent landscape?
- What recent technological innovations have been made in circulating tumor cells?
This patent analysis report provides invaluable insights into circulating tumor cells patent landscape, including technological advancements, key players, and strategic trends. It equips stakeholders with detailed industry intelligence, essential for informed decision-making, competitive analysis, and identifying growth opportunities in a rapidly evolving sector.
- 1 Introduction
- 2 Executive Summary
- 3 Global mRNA Vaccine and Therapeutic Market Overview
- 3.1 Global mRNA Vaccine and Therapeutic Market Historical Value (2017-2023)
- 3.2 Global mRNA Vaccine and Therapeutic Market Forecast Value (2024-2032)
- 4 Global mRNA Vaccine and Therapeutic Market Segmentation
- 4.1 Global mRNA Vaccine and Therapeutic Market Share by Type
- 4.1.1 Market Overview
- 4.1.2 Self-Amplifying mRNA Vaccines
- 4.1.3 Non-Amplifying mRNA Vaccines
- 4.2 Global mRNA Vaccine and Therapeutic Market Share by Route of Administration
- 4.2.1 Market Overview
- 4.2.2 Intravenous
- 4.2.3 Intramuscular
- 4.2.4 Intranasal
- 4.2.5 Others
- 4.3 Global mRNA Vaccine and Therapeutic Market Share by Therapeutic Area
- 4.3.1 Market Overview
- 4.3.2 Infectious Diseases
- 4.3.3 Oncological Disorders
- 4.3.4 Other Disorders
- 5 Global Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 Porter’s Five Forces Analysis
- 5.3 PESTEL Analysis
- 5.4 Industry Events, Initiatives, and Trends
- 5.5 Value Chain Analysis
- 6 Global mRNA Cancer Therapeutics Patent Landscape Analysis
- 6.1 Patent Distribution by Publication Year
- 6.2 Patent Distribution by Application Year
- 6.3 Patent Distribution by Priority Year
- 6.4 Analysis by Type of Patent
- 6.4.1 Granted Patents
- 6.4.2 Patent Application
- 6.4.3 Amended Application
- 6.4.4 Search Report
- 6.5 Analysis by Legal Status
- 6.5.1 Active
- 6.5.2 Pending
- 6.5.3 Expired/Discontinued
- 6.6 Analysis by Patent Jurisdiction
- 6.7 Analysis by Patent Age
- 6.8 Analysis by Cooperative Patent Classification (CPC) Codes
- 6.9 Average Time to Publish a Patent
- 6.9.1 By Entities
- 6.9.2 By Jurisdiction
- 6.9.3 By Technology
- 6.10 Analysis by Type of Entity (Academic and Non-Academic)
- 6.11 Analysis by Top Applicants
- 6.12 Analysis by Top Inventors
- 7 Global mRNA Cancer Therapeutics Patent Analysis by Technology
- 7.1 Total Patents by Top Technologies
- 7.2 Time Evolution of Patents by Technology
- 7.3 Emerging Technologies
- 7.4 Patent Segmentation, By Carrier
- 7.4.1 Time Evolution by Number of Patents
- 7.4.2 Time Evolution by Number of Patent Families
- 7.4.3 Analysis by Type of Entity (Academic vs Non-Academic)
- 7.4.4 Analysis by Top Applicants
- 7.4.5 Analysis by Top Inventors
- 7.5 Patent Segmentation, By Route of Administration
- 7.6 Patent Segmentation, By Delivery Route
- *Complete technology list will be provided in the report.
- 8 EMR Patent Valuation Analysis
- 8.1 Assessment Methodology
- 8.2 High Value Patents
- 8.3 Medium Value Patents
- 8.4 Low Value Patents
- 9 Global mRNA Cancer Therapeutics – Top 10 Players Patent Analysis
- 9.1 Top 10 Entities by Number of Patents
- 9.2 Analysis by Publication Year
- 9.3 Analysis by Application Year
- 9.4 Analysis by Priority Year
- 9.5 Analysis by Type of Patent
- 9.6 Analysis by Jurisdiction
- 9.7 Analysis by Cooperative Patent Classification (CPC) Codes
- 9.8 Analysis by Source of Innovation
- 9.9 Analysis by Forward and Backward Citations
- 9.10 Analysis by Legal Status
- 9.11 Analysis by Patent Age
- 9.12 Analysis by Key Inventors
- 9.13 Entity Dynamics
- 9.13.1 Analysis by Type of Player (Academic vs Non-Academic)
- 9.13.2 Analysis by Collaboration
- 9.13.3 Analysis by Technology
- 9.13.4 Newcomers
- 9.13.4.1 Start-up Companies
- 9.13.4.2 Established Companies
- 10 Patent Profile of Key Players
- 10.1 Pfizer, Inc.
- 10.1.1 Product Portfolio
- 10.1.2 Patent Portfolio by Patent Families
- 10.1.3 Time Evolution of Patents
- 10.1.4 Geographical Patent Coverage
- 10.1.5 Patent Analysis by Technology
- 10.1.6 Patent News and Developments
- 10.1.7 Financial Analysis
- 10.1.8 SWOT Analysis
- 10.2 Modernatx Inc
- 10.3 Novartis AG
- 10.4 Genentech Inc.
- 10.5 Immatics Biotechnologies GmbH
- 11 Future Trends
- 12 Global mRNA Vaccine and Therapeutic Market Landscape (Additional Insight)*
- 12.1 Global mRNA Vaccine and Therapeutic: Developers Landscape
- 12.1.1 Analysis by Year of Establishment
- 12.1.2 Analysis by Company Size
- 12.1.3 Analysis by Region
- 12.2 Global mRNA Vaccine and Therapeutic: Product Landscape
- 12.2.1 Analysis by Product Type
- 12.2.2 Analysis by Technology
- 12.2.3 Analysis by Application
- *Additional insights are not provided in the standard report.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook